Kaleido Biosciences, Inc.
KLDO
$0.002
$0.00191,900.00%
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -10.62% | -10.99% | -12.67% | 0.64% | -- |
| Total Depreciation and Amortization | 29.35% | 43.56% | 44.64% | 45.70% | -- |
| Total Amortization of Deferred Charges | 1.29% | 66.03% | 163.00% | 236.19% | -- |
| Total Other Non-Cash Items | -20.24% | -10.95% | 21.46% | 32.24% | -- |
| Change in Net Operating Assets | -105.78% | 2,770.63% | 377.19% | -89.46% | -- |
| Cash from Operations | -25.32% | -8.14% | -7.05% | 4.66% | -- |
| Capital Expenditure | 71.94% | 68.92% | 33.85% | 15.73% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 82.83% | 68.92% | 33.85% | 15.73% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 99.92% | 99.85% | -- |
| Issuance of Common Stock | 73.62% | 100.81% | 113.14% | 6,513.13% | -- |
| Repurchase of Common Stock | -- | -- | -13.73% | 84.55% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 74.68% | 88.46% | 88.46% | 90.79% | -- |
| Cash from Financing | 73.36% | 69.60% | 80.00% | 1,456.53% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.18% | 104.20% | 103.27% | 156.99% | -- |